Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on SalesTimes Interest Earned

Global Medical REIT (GMRE-PB) EBIT Margin (2016 - 2025)

Global Medical REIT (GMRE-PB) has disclosed EBIT Margin for 10 consecutive years, with 142.09% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin rose 2134650.0% year-over-year to 142.09%, compared with a TTM value of 33366.54% through Dec 2025, down 3393867.0%, and an annual FY2025 reading of 33366.54%, up 1081130.0% over the prior year.
  • EBIT Margin was 142.09% for Q4 2025 at Global Medical REIT, up from 40.76% in the prior quarter.
  • Across five years, EBIT Margin topped out at 159.27% in Q3 2022 and bottomed at 259875.0% in Q4 2022.
  • Average EBIT Margin over 5 years is 20690.73%, with a median of 4.92% recorded in 2022.
  • The sharpest move saw EBIT Margin plummeted -25987465bps in 2022, then surged 25994830bps in 2023.
  • Year by year, EBIT Margin stood at 0.35% in 2021, then plummeted by -74390345bps to 259875.0% in 2022, then surged by 100bps to 73.3% in 2023, then plummeted by -29027bps to 21204.41% in 2024, then surged by 101bps to 142.09% in 2025.
  • Business Quant data shows EBIT Margin for GMRE-PB at 142.09% in Q4 2025, 40.76% in Q3 2025, and 51311.24% in Q2 2025.